BrickBio is a developer of a bioconjugation platform intended for research of site-specific modification of proteins. The company's platform can optimize any conjugate with the selective modification of a number of distinct websites on a single protein through its prokaryotic and eukaryotic expression programs, thereby providing hospitalswith amino acid coupled therapeutics to improve protein characteristics.

Biotechnology

BrickBio, Inc.

BrickBio, Inc.'s headquarters in Boston, MA, United States

Description

People (5)

John Boyce

Abhishek Chatterjee

Colby Souders

Myer Hussain

Zhi Li

Jobs